Atlas Trials

Recombinant Zoster Vaccine in Stable SLE Patients

Clinical trial NCT04516408 · UNKNOWN

Trial details

NCT number
NCT04516408
Sponsor
RenJi Hospital
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Herpes ZosterRecombinant Zoster VaccineSystemic Lupus Erythematosus
Start date
2021-04-20
Primary completion
2023-09-30
Enrollment
464

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.